Breaking News Instant updates and real-time market news.

CRME

Cardiome

$2.76

-0.03 (-1.08%)

, AGN

Allergan

$189.99

-2.23 (-1.16%)

08:02
11/29/16
11/29
08:02
11/29/16
08:02

Cardiome advances towards launching XYDALBA in the UK

Cardiome (CRME) is pleased to announce that it has moved one step closer to launching XYDALBA in the UK by receiving an established price from the Secretary of State for Health, under regulation 3 of the Health Service Branded Medicines Regulations. Commenting on the development, Hugues Sachot, Senior Vice President Commercial at Cardiome said, "We are extremely pleased with the progress that XYDALBA continues to make toward our imminent launch in the UK and other European countries we have under license from Allergan (AGN). The creation of an established price does not guarantee reimbursement in the UK, but it is a critical step in preparation for launch by allowing Cardiome to start negotiating with individual hospitals to gain formulary access for XYDALBA. Cardiome expects to make its first commercial sale in the UK before the end of 2016. We also continue to receive excellent feedback from our other countries as we prepare to offer physicians access to this unique dosage regimen that provides a new treatment approach giving patients, healthcare professionals and hospitals greater flexibility in managing serious skin infections."

CRME

Cardiome

$2.76

-0.03 (-1.08%)

AGN

Allergan

$189.99

-2.23 (-1.16%)

  • 29

    Nov

CRME Cardiome
$2.76

-0.03 (-1.08%)

03/11/16
ADAM
03/11/16
NO CHANGE
Target $10
ADAM
Buy
Cardiome price target lowered to $10 from $16 at Canaccord
Canaccord lowered its price target on Cardiome to $10 from $16 following Q4 results. The firm cited its weak results, lowered guidance for the peak potential for Brinavess in Europe, and significant hurdles that remain for the U.S approval for Brinavess. Canaccord maintained its Buy rating on Cardiome shares.
06/01/16
HCWC
06/01/16
INITIATION
Target $9.5
HCWC
Buy
Cardiome initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth started Cardiome Pharma with a Buy rating and $9.50 price target.
08/02/16
ADAM
08/02/16
NO CHANGE
Target $9
ADAM
Speculative Buy
Cardiome price target lowered to $9 from $13.75 at Canaccord
Canaccord lowered its price target on Cardiome to $9 from $13.75 following its secondary offering of shares at a "big discount" to the previous closing of the stock. The firm believes the discount has presented a buying opportunity, as the recent licensing deal for Xydalba accelerates the company's transformation into a European hospital-focused specialty pharmaceuticals company. Canaccord reiterated its Speculative Buy rating on Cardiome shares.
AGN Allergan
$189.99

-2.23 (-1.16%)

11/04/16
UBSW
11/04/16
NO CHANGE
Target $240
UBSW
Buy
Allergan price target lowered to $240 from $300 at UBS
UBS analyst Marc Goodman lowered his price target on Allergan to $240 from $300 following disappointing Q3 results and a lowering of his estimates. However, Goodman reiterated his Buy rating on Allergan shares, on the belief it is still a good growth story, has an efficient tax structure and robust pipeline, and has the potential to put up double digit earnings growth for the rest of the decade.
11/21/16
WBLR
11/21/16
INITIATION
Target $209
WBLR
Market Perform
Allergan initiated with a Market Perform at William Blair
William Blair analyst Tim Lugo started Allergan with a Market Perform rating and $209 price target. The analyst views the company as high quality but sees headwinds in 2017 and 2018. Renewed competition for Botox could weigh on out-year estimates while a Namenda generic could come sooner than expected, Lugo tells investors in a research note.
11/21/16
11/21/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Netflix (NFLX) initiated with a Buy at Brean Capital. 2. Allergan (AGN) initiated with a Market Perform at William Blair. 3. Myovant Sciences (MYOV) was initiated with an Overweight at Barclays, an Outperform at JMP Securities, an Outperform at Baird, a Buy at Citi, and an Outperform at Cowen. 4. RA Pharmaceuticals (RARX) was initiated with a Buy at Jefferies, a Buy at SunTrust, and an Outperform at Credit Suisse. 5. ZTO Express (ZTO) was initiated with a Buy ratings at Citi and Goldman and an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/23/16
JMPS
11/23/16
NO CHANGE
JMPS
Adamas could have positive read through from Allergan deal, says JMP Securities
After Adamas' partner, Allergan (AGN), agreed to buy Chase Pharmaceuticals, JMP Securities analyst Jason Butler thinks that the deal could have positive implications for Adamas Pharmaceuticals and its Alzheimer's treatment, Namzaric, a combination therapy which blocks a neutrotransmitter. The analyst says that the deal "reinforces Allergan's long-term commitment to neurotransmitter focused" Alzheimer;s treatments and provides the opportunity for Chase's drug to be combined with Namzaric. The analyst thinks that such a combined drug could gain additional market share. He keeps a $29 price target and an Outperform rating on Adamas.

TODAY'S FREE FLY STORIES

CHDN

Churchill Downs

$172.00

2.65 (1.56%)

11:01
04/27/17
04/27
11:01
04/27/17
11:01
Recommendations
Churchill Downs analyst commentary  »

Churchill Downs price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

11:01
04/27/17
04/27
11:01
04/27/17
11:01
General news
Kansas City Fed Manufacturing Index Level data reported »

April Kansas City Fed…

XOP

SPDR Oil Exploration and Production Fund

$34.82

-1.055 (-2.94%)

11:01
04/27/17
04/27
11:01
04/27/17
11:01
Options
Notable option block in SPDR Oil Exploration and Production ETF »

Notable option block in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:00
04/27/17
04/27
11:00
04/27/17
11:00
General news
Treasury Action: Treasury bulls are getting some traction »

Treasury Action: Treasury…

VIVO

Meridian Bioscience

$14.20

0.2 (1.43%)

10:59
04/27/17
04/27
10:59
04/27/17
10:59
Recommendations
Meridian Bioscience analyst commentary  »

Raymond James…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

DISH

Dish

$63.30

0.76 (1.22%)

, S

Sprint

$8.99

0.075 (0.84%)

10:56
04/27/17
04/27
10:56
04/27/17
10:56
Hot Stocks
Barclays upgrades Dish on potential for deal with carriers »

The shares of Dish (DISH)…

DISH

Dish

$63.30

0.76 (1.22%)

S

Sprint

$8.99

0.075 (0.84%)

TMUS

T-Mobile

$67.58

0.23 (0.34%)

T

AT&T

$40.31

-0.13 (-0.32%)

VZ

Verizon

$47.03

-0.3299 (-0.70%)

STRP

Straight Path

$131.94

1.67 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 01

    May

  • 03

    May

  • 09

    May

  • 16

    May

  • 17

    May

10:55
04/27/17
04/27
10:55
04/27/17
10:55
General news
Treasury Option Action: call positioning in the 10-year »

Treasury Option Action:…

KKR

KKR

$18.85

1.075 (6.05%)

10:53
04/27/17
04/27
10:53
04/27/17
10:53
Hot Stocks
KKR 'welcomes' ValueAct investment, Reuters reports »

KKR has held talks with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

DCM

NTT DoCoMo

$23.87

0.68 (2.93%)

10:51
04/27/17
04/27
10:51
04/27/17
10:51
Downgrade
NTT DoCoMo rating change  »

NTT DoCoMo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFN

Infinera

$9.98

-0.16 (-1.58%)

10:51
04/27/17
04/27
10:51
04/27/17
10:51
Options
Opening interest in Infinera June calls ahead of earnings »

Opening interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 09

    May

JNJ

Johnson & Johnson

$123.52

0.01 (0.01%)

10:49
04/27/17
04/27
10:49
04/27/17
10:49
Hot Stocks
Johnson & Johnson raises dividend 5% to 84c per share »

Johnson & Johns…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 05

    May

  • 06

    Jun

FB

Facebook

$146.56

0.07 (0.05%)

, GOOG

Alphabet

$871.73

-0.57 (-0.07%)

10:49
04/27/17
04/27
10:49
04/27/17
10:49
Periodicals
Facebook, Google defrauded in $100M payment scam, Fortune says »

Facebook (FB) and Google…

FB

Facebook

$146.56

0.07 (0.05%)

GOOG

Alphabet

$871.73

-0.57 (-0.07%)

GOOGL

Alphabet Class A

$889.14

0.3 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 03

    May

  • 08

    May

  • 16

    May

  • 22

    May

MSFT

Microsoft

$67.83

-0.09 (-0.13%)

, CASY

Casey's General Stores

$114.17

0.47 (0.41%)

10:48
04/27/17
04/27
10:48
04/27/17
10:48
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

MSFT

Microsoft

$67.83

-0.09 (-0.13%)

CASY

Casey's General Stores

$114.17

0.47 (0.41%)

SXL

Sunoco Logistics

$23.78

-0.49 (-2.02%)

BTU

Peabody Energy

$26.57

0.04 (0.15%)

DXCM

Dexcom

$75.68

0.74 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 02

    May

  • 04

    May

  • 09

    May

  • 23

    May

LLY

Eli Lilly

$81.29

0.33 (0.41%)

, AAL

American Airlines

$46.40

-0.21 (-0.45%)

10:48
04/27/17
04/27
10:48
04/27/17
10:48
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

LLY

Eli Lilly

$81.29

0.33 (0.41%)

AAL

American Airlines

$46.40

-0.21 (-0.45%)

BWLD

Buffalo Wild Wings

$162.40

-0.4 (-0.25%)

WYN

Wyndham

$99.38

-1.16 (-1.15%)

RBS

RBS

$6.53

0.035 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 04

    May

  • 07

    May

  • 31

    May

CSCO

Cisco

$33.40

-0.02 (-0.06%)

, MCD

McDonald's

$142.18

1.335 (0.95%)

10:48
04/27/17
04/27
10:48
04/27/17
10:48
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

CSCO

Cisco

$33.40

-0.02 (-0.06%)

MCD

McDonald's

$142.18

1.335 (0.95%)

AXP

American Express

$80.41

-0.11 (-0.14%)

PYPL

PayPal

$44.41

-0.3 (-0.67%)

DISH

Dish

$63.30

0.76 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 01

    May

  • 01

    May

  • 31

    May

  • 12

    Jun

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

DSPG

DSP Group

$12.40

0.35 (2.90%)

10:45
04/27/17
04/27
10:45
04/27/17
10:45
Hot Stocks
DSP Group moves up after forecasting sequential increase in Q2 revenue »

Shares of DSP Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 01

    May

  • 02

    May

  • 03

    May

  • 04

    May

  • 09

    May

  • 15

    May

  • 15

    May

10:45
04/27/17
04/27
10:45
04/27/17
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

10:45
04/27/17
04/27
10:45
04/27/17
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

SNCR

Synchronoss

$24.62

-0.02 (-0.08%)

10:42
04/27/17
04/27
10:42
04/27/17
10:42
Downgrade
Synchronoss rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

CMCSA

Comcast

$38.79

0.3 (0.78%)

10:41
04/27/17
04/27
10:41
04/27/17
10:41
Options
Large call spread in Comcast as shares rally on earnings »

Large call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

10:35
04/27/17
04/27
10:35
04/27/17
10:35
General news
Today's U.S. reports »

Today's U.S. reports…

RBS

RBS

$6.55

0.06 (0.92%)

10:31
04/27/17
04/27
10:31
04/27/17
10:31
Options
Pre-earnings call write in Royal Bank of Scotland »

Pre-earnings call write…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
04/27/17
04/27
10:30
04/27/17
10:30
General news
EIA natural gas storage change for week ending April 21 »

Gas inventories 74 Bcf…

CHKP

Check Point

$104.22

-1.14 (-1.08%)

, CUDA

Barracuda

$20.40

0.265 (1.32%)

10:28
04/27/17
04/27
10:28
04/27/17
10:28
Hot Stocks
Check Point Q1 results beat expectations as company backs FY17 outlook »

Shares of Check Point…

CHKP

Check Point

$104.22

-1.14 (-1.08%)

CUDA

Barracuda

$20.40

0.265 (1.32%)

IMPV

Imperva

$43.25

-0.25 (-0.57%)

FFIV

F5 Networks

$137.30

-0.89 (-0.64%)

SYMC

Symantec

FTNT

Fortinet

$39.90

-0.37 (-0.92%)

FEYE

FireEye

$12.56

-0.1 (-0.79%)

PANW

Palo Alto Networks

$110.33

1.06 (0.97%)

PFPT

Proofpoint

$77.46

-1.19 (-1.51%)

QLYS

Qualys

$37.90

-0.15 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 02

    May

  • 02

    May

  • 04

    May

  • 08

    May

  • 09

    May

  • 10

    May

  • 08

    Jun

  • 08

    Jun

  • 12

    Jun

DAL

Delta Air Lines

$45.25

-1.125 (-2.43%)

10:26
04/27/17
04/27
10:26
04/27/17
10:26
Options
Delta Air Lines call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.